IL17A and polyposis: We previously showed that ablation of IL-17A in Apc/Min+ mice achieved approximately 90% inhibition of polyposis even at 20 weeks, suggesting that the effect of IL-17A deficiency is long-lasting to inhibit the formation of a tumor microenvironment [17].